Published in Surgery on April 01, 1968
Venous bypass in clinical liver transplantation. Ann Surg (1984) 7.04
Orthotopic homotransplantation of the human liver. Ann Surg (1968) 6.64
Liver transplantation in man. I. Observations on technique and organization in five cases. Br Med J (1968) 4.38
The role of liver transplantation in hepatobiliary malignancy. A retrospective analysis of 95 patients with particular regard to tumor stage and recurrence. Ann Surg (1989) 2.71
Orthotopic and heterotopic liver homografts in man. Ann Surg (1970) 2.63
Specific bacteriologic problems after orthotopic liver transplantation in dogs and pigs. Arch Surg (1968) 2.32
Major hepatic resection using vascular isolation and hypothermic perfusion. Ann Surg (1974) 2.30
Heterologous antilymphocyte glubulin, histoincompatiblity matching, and human renal homotransplantation. Surg Gynecol Obstet (1968) 2.23
Coagulation during and after orthotopic transplantation of the human liver. Arch Surg (1969) 2.03
Infections in recipients of liver homografts. N Engl J Med (1968) 1.92
Changes in serum haptoglobin and group specific component after orthotopic liver homotransplantation in humans. Proc Soc Exp Biol Med (1968) 1.68
Liver transplantation in man. II. A report of two orthotopic liver transplants in adult recipients. Br Med J (1968) 1.68
A trial with heterologous antilymphocyte globulin in man. Transplant Proc (1969) 1.51
Clinical and pathologic observations after orthotopic transplantation of the human liver. Surg Gynecol Obstet (1969) 1.51
The hepatopulmonary syndrome: new name, old complexities. Thorax (1992) 1.44
Liver transplantation in children with biliary atresia and vascular anomalies. J Pediatr Surg (1974) 1.41
The effect of liver disease on the need for venous decompression during the anhepatic phase of canine orthotopic liver transplantation. Surgery (1970) 1.38
Liver transplantation in man--IV, Haemorrhage and thrombosis. Br Med J (1969) 1.14
Diagnosis of hepatopulmonary syndrome with contrast transesophageal echocardiography: advantages over contrast transthoracic echocardiography. Dig Dis Sci (1999) 1.03
Liver transplantation: where it's been and where it's going. Gastroenterol Clin North Am (1988) 1.01
Prevalence and reversibility of the hepatopulmonary syndrome after liver transplantation. The Cleveland Clinic experience. West J Med (1995) 0.96
Radioisotope scanning in experimental and clinical orthotopic liver transplantation. Surg Gynecol Obstet (1968) 0.88
Liver transplantation for hepatocellular carcinoma: clinical results and future aspects. Cancer Chemother Pharmacol (1992) 0.88
Intrapulmonary shunting in the biliary atresia/polysplenia syndrome: reversal after liver transplantation. Arch Dis Child (1994) 0.82
Organ transplantation, past and present. Surg Clin North Am (1968) 0.79
Technical feasibility of liver transplantation without cold storage. Langenbecks Arch Surg (2013) 0.77
Radionuclides in the postoperative management of orthotopic human organ transplantation. Radiology (1969) 0.76
THE USE OF HETEROLOGOUS ANTILYMPHOCYTE GLOBULIN (ALG) IN HUMAN RENAL AND LIVER TRANSPLANTATION. Int Congr Ser (1967) 0.76
Orthotopic liver transplantation in man. Transplant Proc (1969) 0.76
Liver scans after orthotopic hepatic homotransplantation, biliary obstruction, and devascularization procedures. Surg Forum (1968) 0.75
Effect of external pressure on oxygen utilization by the liver. Ann Surg (1970) 0.75
Liver transplantation. Gut (1968) 0.75
Transplantation of the liver. Br Med J (1968) 0.75
Experimental appraisal of factors involved in provision of donor livers. Br Med J (1969) 0.75
Graft Reconditioning before Liver Transplantation. Visc Med (2016) 0.75
Auto-allergic reactions following internal irradiation of the liver. Immunology (1969) 0.75
Renal transplantation in patients with carcinoma. Br Med J (1974) 0.75
The corneal transplant score: a simple corneal graft candidate calculator. Graefes Arch Clin Exp Ophthalmol (2013) 0.75
Ushering in the era of penile transplantation. Transl Androl Urol (2017) 0.75
HOMOTRANSPLANTATION OF THE LIVER IN HUMANS. Surg Gynecol Obstet (1963) 10.22
The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation. Surg Gynecol Obstet (1967) 7.24
FACTORS DETERMINING SHORT- AND LONG-TERM SURVIVAL AFTER ORTHOTOPIC LIVER HOMOTRANSPLANTATION IN THE DOG. Surgery (1965) 6.71
Serotyping for homotransplantation. X. Survival of 196 grafted kidneys subsequent to typing. Transplantation (1967) 4.16
IMMUNOSUPPRESSION AFTER EXPERIMENTAL AND CLINICAL HOMOTRANSPLANTATION OF THE LIVER. Ann Surg (1964) 4.14
Zone electrophoresis in starch gels and its application to studies of serum proteins. Adv Protein Chem (1959) 3.47
Changes in blood coagulation. Arch Surg (1966) 3.22
Multiple pulmonary arteriovenous fistulas in juvenile cirrhosis. Am J Med (1956) 2.76
Studies of blood flow and ultrastructural changes in rejecting and nonrejecting canine orthotopic liver homografts. Surgery (1968) 2.58
IMMUNOSUPPRESSION AND VASCULAR INSUFFICIENCY IN LIVER TRANSPLANTATION. Ann N Y Acad Sci (1964) 2.29
Heterologous antilymphocyte glubulin, histoincompatiblity matching, and human renal homotransplantation. Surg Gynecol Obstet (1968) 2.23
Orthotopic autotransplantation and allotransplantation of the liver: functional and structural patterns in the dog. Ann Surg (1967) 2.17
[ATTEMPTED HEPATIC HOMOGRAFT]. Mem Acad Chir (Paris) (1964) 1.84
Progress in homotransplantation of the liver. Adv Surg (1966) 1.83
Platelet changes following clinical and experimental hepatic homotransplantation. Arch Surg (1968) 1.78
Auxiliary liver transplantation: effect of host portacaval shunt. Experimental and clinical observations. Arch Surg (1966) 1.66
Changes in coagulation and fibrinolysis after orthotopic canine liver homotransplantation. J Lab Clin Med (1969) 1.63
SUCCESSFUL ORTHOTOPIC TRANSPLANTATION OF LIVER HOMOGRAFTS AFTER EIGHT TO TWENTY-FIVE HOURS PRESERVATION. Surg Forum (1967) 1.37
Study of clotting factors in liver homotransplantation. Am J Surg (1966) 1.35
Syndrome of cyanosis, digital clubbing, and hepatic disease in siblings. J Pediatr (1968) 1.30
TREATMENT OF "TOXEMIA" AFTER EXTREMITY REPLANTATION. Arch Surg (1964) 1.11
Evolution of liver transplantation. Hepatology (1982) 19.54
A flexible procedure for multiple cadaveric organ procurement. Surg Gynecol Obstet (1984) 10.33
Orthotopic liver transplantation in ninety-three patients. Surg Gynecol Obstet (1976) 8.11
The use of cyclosporin A and prednisone in cadaver kidney transplantation. Surg Gynecol Obstet (1980) 7.40
The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation. Surg Gynecol Obstet (1967) 7.24
Fifteen years of clinical liver transplantation. Gastroenterology (1979) 7.19
Venous bypass in clinical liver transplantation. Ann Surg (1984) 7.04
Liver transplantation with use of cyclosporin a and prednisone. N Engl J Med (1981) 6.95
Orthotopic homotransplantation of the human liver. Ann Surg (1968) 6.64
Vascular homografts from cadaveric organ donors. Surg Gynecol Obstet (1979) 6.23
Long survival in rats after multivisceral versus isolated small-bowel allotransplantation under FK 506. Surgery (1991) 5.92
Infections after liver transplantation. An analysis of 101 consecutive cases. Medicine (Baltimore) (1988) 5.77
Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet (1984) 5.74
Refinements in the surgical technique of liver transplantation. Semin Liver Dis (1985) 5.70
Progress in and deterrents to orthotopic liver transplantation, with special reference to survival, resistance to hyperacute rejection, and biliary duct reconstruction. Transplant Proc (1974) 5.53
Cyclophosphamide and whole organ transplantation in human beings. Surg Gynecol Obstet (1971) 5.24
Alternative methods of arterialization of the hepatic graft. Surg Gynecol Obstet (1984) 5.16
Immunosuppression of canine, monkey, and baboon allografts by FK 506: with special reference to synergism with other drugs and to tolerance induction. Surgery (1988) 5.03
Liver, kidney, and thoracic organ transplantation under FK 506. Ann Surg (1990) 5.01
Respiratory virus immunization. I. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine. Am J Epidemiol (1969) 4.97
Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications. Transplant Proc (1990) 4.90
Pancreaticoduodenal transplantation in humans. Surg Gynecol Obstet (1984) 4.49
Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology (1994) 4.32
A simplified technique for revascularization of homografts of the liver with a variant right hepatic artery from the superior mesenteric artery. Surg Gynecol Obstet (1985) 4.29
The association of viral and bacterial respiratory infections with exacerbations of wheezing in young asthmatic children. J Pediatr (1973) 4.22
Heterotopic heart transplantation in the rat receiving FK-506 alone or with cyclosporine. Transplant Proc (1987) 4.21
Pancreatic islet transplantation after upper abdominal exenteration and liver replacement. Lancet (1990) 4.18
Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery (1994) 4.16
Orthotopic liver transplantation with preservation of the inferior vena cava. Ann Surg (1989) 4.12
Malignant lymphomas in transplantation patients. Transplant Proc (1969) 4.12
Role of liver transplantation in cancer therapy. Ann Surg (1985) 4.08
Biliary complications after liver transplantation: with special reference to the biliary cast syndrome and techniques of secondary duct repair. Surgery (1977) 4.08
Shwartzman reaction after human renal homotransplantation. N Engl J Med (1968) 4.05
Altered reactivity to measles virus. Atypical measles in children previously immunized with inactivated measles virus vaccines. JAMA (1967) 4.01
Extended preservation of human liver grafts with UW solution. JAMA (1989) 3.99
Canine and human liver preservation for 6 to 18 hr by cold infusion. Transplantation (1977) 3.99
Clinical presentation of hepatic artery thrombosis after liver transplantation in the cyclosporine era. Transplantation (1985) 3.91
The preparation and testing of horse antidog and antihuman antilymphoid plasma or serum and its protein fractions. Surg Gynecol Obstet (1967) 3.86
Replacement of donor lymphoid tissue in small-bowel transplants. Lancet (1991) 3.85
The origin, hormonal nature, and action of hepatotrophic substances in portal venous blood. Surg Gynecol Obstet (1973) 3.84
Effects of insulin, glucagon, and insuling/glucagon infusions on liver morphology and cell division after complete portacaval shunt in dogs. Lancet (1976) 3.74
Immunosuppressive effect of FK-506 on in vitro lymphocyte alloactivation: synergism with cyclosporine A. Transplant Proc (1987) 3.73
Hepatic trisegmentectomy and other liver resections. Surg Gynecol Obstet (1975) 3.66
Right trisegmentectomy for hepatic neoplasms. Surg Gynecol Obstet (1980) 3.64
Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway rats. Transplantation (1995) 3.63
Hepatic Retransplantation. Transplant Proc (1985) 3.62
Neonatal pulmonary ischemia. I. Clinical and physiological studies. Pediatrics (1967) 3.60
Transplantation of multiple abdominal viscera. JAMA (1989) 3.59
Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg (1991) 3.57
Canine liver transplantation under Nva2-cyclosporine versus cyclosporine. Transplantation (1986) 3.54
Combination donor hepatectomy and nephrectomy and early functional results of allografts. Surg Gynecol Obstet (1982) 3.49
Cadaveric renal transplantation. An analysis of 65 cases. Lancet (1969) 3.48
Selected topics on FK 506, with special references to rescue of extrahepatic whole organ grafts, transplantation of "forbidden organs," side effects, mechanisms, and practical pharmacokinetics. Transplant Proc (1991) 3.40
Nephrotoxicity of cyclosporin A in liver and kidney transplant patients. Lancet (1981) 3.38
The relation of preoperative coagulation findings to diagnosis, blood usage, and survival in adult liver transplantation. Transplantation (1985) 3.38
Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology (1991) 3.34
Kidney transplantation under FK 506 immunosuppression. Transplant Proc (1991) 3.31
Early trials with FK 506 as primary treatment in liver transplantation. Transplant Proc (1990) 3.29
Use of OKT3 with cyclosporin and steroids for reversal of acute kidney and liver allograft rejection. Nephron (1987) 3.26
Delayed biliary duct obstruction after orthotopic liver transplantation. Surgery (1972) 3.26
The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol (1988) 3.24
Changes in blood coagulation. Arch Surg (1966) 3.22
Rejection of multivisceral allografts in rats: a sequential analysis with comparison to isolated orthotopic small-bowel and liver grafts. Surgery (1990) 3.18
Renal transplantation in baboons under FK 506. Surgery (1989) 3.17
Intraoperative changes in blood coagulation and thrombelastographic monitoring in liver transplantation. Anesth Analg (1985) 3.17
Pathology of hepatic transplantation: A review of 62 adult allograft recipients immunosuppressed with a cyclosporine/steroid regimen. Am J Pathol (1985) 3.16
Liver transplantation before 1 year of age. J Pediatr (1987) 3.15
In Vitro Immunosuppressive Effects of FK506 in Combination With Other Drugs. Transplant Proc (1988) 3.15
The effect of graft function on FK506 plasma levels, dosages, and renal function, with particular reference to the liver. Transplantation (1991) 3.14
Fungal infections in liver transplant recipients. Transplantation (1985) 3.07
De novo malignant tumors in organ transplant recipients. Transplant Proc (1971) 3.03
Experience with 150 liver resections. Ann Surg (1983) 3.01